Azilsartan/chlorthalidone combination therapy for blood pressure control
{{output}}
Background: Edarbyclor(®) is a combined angiotensin receptor blocker (ARB) and thiazide-like diuretic (azilsartan and chlorthalidone), and was approved on December 20, 2011 by the US Food and Drug Administration (FDA) for hypert... ...
